Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections

NCT04828694 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid-use Disorder

Interventions

DRUG: BICX104
DRUG: Vivitrol

Sponsor

BioCorRx Inc

Collaborators

[object Object]
[object Object]